Publication | Closed Access

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma

MedicineMetronomic TherapyCisplatin CombinationPathologyPhase Ii StudyCancer TreatmentOncologyRadiation OncologyChinese Patients